kff employer health benefits survey 2025 glp-1 coverage In 2025: Family Premiums Rise 6 Percent, Large Employers Increase Of GLP-1s For Weight Loss Annual Family Premiums for Employer

Tirzepatide safety data Tirzepatide safety data comes from the SURPASS and SURMOUNT trial programs involving thousands of subjects

Post-accident testing After workplace accidents, employers may require drug testing to determine if impairment contributed

Suicidal Ideation and Other Rare Undesirable Effects With the expanding role in diabetes and obesity, as well as potential extending therapeutic uses in the neurological area (e.g., stroke, neurodegenerative disorders, alcohol- and substance-use disorders), rare side effects have recently emerged

We don't want to encourage trailing edge, Victorian era manufacturing in the U.S

Follow your doctors advice and do not stop treatment abruptly

Hormonal and blood-sugar disruption, including elevated cortisol and prolactin, reduced insulin sensitivity, and hypoglycemia risk tied to IGF-1 receptor activity